Australia markets open in 2 hours 13 minutes

Mural Oncology plc (MURA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.3400+0.1100 (+3.41%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 54.66M
Enterprise value -163.52M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.23
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-8.24%
S&P500 52-week change 323.99%
52-week high 36.2500
52-week low 33.1600
50-day moving average 33.9084
200-day moving average 34.3455

Share statistics

Avg vol (3-month) 3183.4k
Avg vol (10-day) 3132.2k
Shares outstanding 516.92M
Implied shares outstanding 616.92M
Float 815.26M
% held by insiders 12.38%
% held by institutions 177.93%
Shares short (15 May 2024) 41.4M
Short ratio (15 May 2024) 49.53
Short % of float (15 May 2024) 48.27%
Short % of shares outstanding (15 May 2024) 48.27%
Shares short (prior month 15 Apr 2024) 41.33M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)-179.96%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -181.63M
Net income avi to common (ttm)-191.9M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)231.67M
Total cash per share (mrq)13.69
Total debt (mrq)13.49M
Total debt/equity (mrq)5.74%
Current ratio (mrq)11.27
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-175.85M
Levered free cash flow (ttm)N/A